Cyclic hormone replacement therapy using quarterly progestin

Obstetrics and Gynecology

Volumn 83, Issue 5, 1994, Pages 693-700

  Ettinger, Bruce ^a,b   Selby, Joseph ^a,b   Citron, John T ^a,b   Vangessel, Arline ^a,b   Ettinger, Vivian M ^a,b   Hendrickson, Michael R ^a,b  

^a DIVISION OF RESEARCH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDROXYPROGESTERONE; MENSTRUATION; MIDDLE AGED; PATIENT SATISFACTION; POSTMENOPAUSE; TIME FACTORS; UTERINE HEMORRHAGE;

EID: 0028232734     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975;293:1167-70.
2. Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975;293:1164-7.
3. Sturdee DW, Wade-Evans T, Paterson MEL, Thom M, Studd JWW. Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women. Br Med J 1978;1:1575-7.
4. Gambrell RD Jr, Castaneda TA, Ricci CA. Management of postmenopausal bleeding to prevent endometrial cancer. Maturitas 1978;1:99-106.
5. Ross RK, Paganini-Hill A, Roy S, Chao A, Henderson BE. Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: Possible implications for public health. Am J Public Health 1988;78:516-9.
6. Utian WH. Consensus statement on progestin use in postmenopausal women [editorial]. Maturitas 1988;11:175-7.
7. Gelfand MM, Ferenczy A. A prospective 1-year study of estrogen and progestin in postmenopausal women: Effects on the endometrium. Obstet Gynecol 1989;74:398-402.
8. Weinstein L, Bewtra C, Gallagher JC. Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient. Am J Obstet Gynecol 1990;162:1534-42.
9. Marslew U, Riis B, Christiansen C. Progestogens: Therapeutic and adverse effects in early post-menopausal women. Maturitas 1991;13:7-16.
10. Magos AL, Brewster E, Singh R, O’Dowd T, Brincat M, Studd JWW. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: A model for the premenstrual syndrome. Br J Obstet Gynaecol 1986;93:1290-6.
11. Grady D, Ernster V. Invited commentary: Does postmenopausal hormone therapy cause breast cancer? Am J Epidemiol 1991;134:1396-400.
12. Staffa JA, Newschaffer CJ, Jones JK, Miller V. Progestins and breast cancer: An epidemiologic review. Fertil Steril 1992;57:473-91.
13. Jensen J, Nilas L, Christiansen C. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy. Br J Obstet Gynaecol 1986;93:613-8.
14. Sarrel P. Effects of ovarian steroids on the cardiovascular system. In: Ginsburg J, ed. The circulation in the female: From the cradle to the grave. Park Ridge, New Jersey: Parthenon Publishing Group, 1989:117-41.
15. Hendrickson MR, Kempson RL. Surgical pathology of the uterine corpus. In: Bennington J, ed. Major problems in pathology. Philadelphia: WB Saunders, 1980.
16. Hendrickson MR, Kempson RL. The uterine corpus. In: Stern-berg S, ed. Diagnostic surgical pathology. 2nd ed. New York: Raven Press, 1994:2091-193.
17. Hendrickson MR, Kempson RL. Endometrial epithelial metaplasias: Proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol 1980;4:525-42.
18. Schiff I, Sela HK, Cramer D, Tulchinsky D, Ryan KJ. Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril 1982;37:79-82.
19. Paterson MEL, Wade-Evans T, Sturdee DW, Thom MH, Studd JWW. Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J 1980;1:822-4.
20. Whitehead MI. The effects of oestrogens and progestogens on the postmenopausal endometrium. Maturitas 1978;1:87-98.
21. Clisham PR, Cedars MI, Greendale G, Fu YS, Gambone J, Judd HL. Long-term transdermal estradiol therapy: Effects on endometrial histology and bleeding patterns. Obstet Gynecol 1992;79:196-201.
22. David A, Reif A, Weissglas L. Cyclic and combined hormonal treatment regimen in postmenopausal women: Hysteroscopic findings. In: Fioretti P, ed. Postmenopausal hormonal therapy: Benefits and risks. New York: Raven Press, 1987:77-81.
23. Kemp JF, Fryer JA, Baber RJ. An alternative regimen of hormone replacement therapy to improve patient compliance. Aust N Z J Obstet Gynaecol 1989;29:66-9.
24. Schwartzbaum JA, Hulka BS, Fowler WC Jr, Kaufman DG, Hoberman D. The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer. Am J Epidemiol 1987;126:851-60.
25. Brinton LA, Hoover RN, The Endometrial Cancer Collaborative Group. Estrogen replacement therapy and endometrial cancer risk: Unresolved issues. Obstet Gynecol 1993;81:265-71.
26. Collins J, Donner A, Allen LH, Adams O. Oestrogen use and survival in endometrial cancer. Lancet 1980;2:961-3.
27. Paganini-Hill A, Ross RK, Henderson BE. Endometrial cancer and patterns of use of oestrogen replacement therapy: A cohort study. Br J Cancer 1989;59:445-7.
28. Ettinger B, Golditch IM, Friedman G. Gynecologic consequences of long-term, unopposed estrogen replacement therapy. Maturitas 1988;10:271-82.
29. Haenggi W, Birkhaeuser MH. A new peroral estrogen/progestin combination for postmenopausal hormonal substitution: An open multicentric field study. Maturitas 1993;16:111-22.
30. Lin MC, Gosink BB, Wolf SI, et al. Endometrial thickness after menopause: Effect of hormone replacement. Radiology 1991;180:427-32.
31. Pirhonen JP, Vuento MH, Mäkinen JI, Salmi TA. Long-term effects of hormone replacement therapy on the uterus and on uterine circulation. Am J Obstet Gynecol 1993;168:620-3.
32. Meuwissen JHJM, van Langen H, Moret E, Navarro-Morquecho I. Monitoring of oestrogen replacement therapy by vaginosonog-raphy of the endometrium. Maturitas 1992;15:33-7.
33. Flowers CE Jr, Wilborn WH, Hyde BM. Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin. Obstet Gynecol 1983;61:135-43.